Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.99% vs 5.57% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -19.47% vs 36.97% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -44.72% vs -0.35% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs -10.71% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Huaren Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.99% vs 5.57% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 18.57% vs -22.06% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -19.47% vs 36.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -23.53% vs -57.65% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -44.72% vs -0.35% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -55.71% vs -39.25% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs -10.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -20.61% vs -13.82% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






